Loading...

CSL Limited

CMXHF•PNK
Healthcare
Biotechnology
$90.00
$-0.49(-0.54%)
U.S. Market is Open • 09:46

CSL Limited (CMXHF) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap43.7B
P/E Ratio30.23
EPS (TTM)$6.17
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$94.37
3 Months$96.61
1 Year Target$105.96

CMXHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CMXHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $105.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.23 and a market capitalization of 43.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.54%
5-Day Change
-1.79%
1-Month Change
-5.82%
3-Month Change
-28.60%
6-Month Change
-16.85%
Year-to-Date (YTD) Change
-22.08%
1-Year Change
-42.57%
3-Year Change
-54.62%
5-Year Change
-57.08%
All-Time (Max) Change
3258.21%

Contact Information

https://www.csl.com.au
61 3 9389 1911
45 Poplar Road, Melbourne, VIC, 3052

Company Facts

32,698 Employees
IPO DateNov 18, 2005
CountryAU
Actively Trading

Frequently Asked Questions